I did some research on Amgen Inc. Amgen is up 6.84% in sales with 5.8B in revenues with Net Income of $2.2B.
Quarter Financials as of June 2017
Gross Profit margin 81.26% – Amgen is doing well, .81 is close to the ideal 1 so they are efficiently spending
Operating profit margin 46.93% – (Operating income is $2.7B) So operating income is 49% of revenue
Net profit margin 37.2% Amgen’s NPM improved from Q4 2016 to Q1 2017 and from Q12017 to Q2 2017
ROE 25.77% Amgen is doing well with over 25% ROE shows how much profit a company generates with the money shareholders have invested. As dag56 pointed out average is about 10% so Amgen is valued high.
ROA 10.27% Amgen’s ROA improved from Q4106 TO Q1 2017 and from Q12017 to Q22017
ROI 11.97% which is up from last quarter (11.87%) and remains healthy
Current ratio 6.19 which very good because it means they have enough assets to pay off their debt as bb254 mentions

Overall, Amgen is a very healthy company.
https://www.stock-analysis-on.net/NASDAQ/Company/Amgen-Inc/Ratios/Profitability
http://www.marketwatch.com/investing/stock/amgn/financials/income/quarter